The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of clinical and pathologic criteria in neuroendocrine and aggressive variant prostate cancer.
 
Beerinder S. Karir
No Relationships to Disclose
 
Panagiotis J. Vlachostergios
No Relationships to Disclose
 
Paul J. Christos
No Relationships to Disclose
 
Victor RA Febles
No Relationships to Disclose
 
Kavya Pinto-Chengot
No Relationships to Disclose
 
Ana M. Molina
Honoraria - ASCO
Consulting or Advisory Role - AVEO; Bayer/Onyx
Research Funding - Eisai (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Eisai
 
David M. Nanus
No Relationships to Disclose
 
Himisha Beltran
Consulting or Advisory Role - Bayer
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst)
 
Scott T. Tagawa
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation; Sanofi
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst)